<?xml version="1.0" encoding="utf-8" ?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
         xmlns="http://purl.org/rss/1.0/">




    



<channel rdf:about="http://www.exac.com/investors/news-1/2005/RSS">
  <title>2005</title>
  <link>http://www.exac.com</link>
  
  <description>
    
       2005 Press Releases
       
  </description>
  
  
  
            <syn:updatePeriod>daily</syn:updatePeriod>
            <syn:updateFrequency>1</syn:updateFrequency>
            <syn:updateBase>2007-12-11T15:24:27Z</syn:updateBase>
        
  
  <image rdf:resource="http://www.exac.com/spacer.gif"/>

  <items>
    <rdf:Seq>
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-q3-revenue-up-10-to-21.5m-net-income-1.7m"/>
        
        
            <rdf:li rdf:resource="http://www.exac.com/news/exactech-announces-fda-clearance-of-connexion-gxl"/>
        
    </rdf:Seq>
  </items>

</channel>

    <item rdf:about="http://www.exac.com/news/exactech-q3-revenue-up-10-to-21.5m-net-income-1.7m">        <title>Exactech Q3 Revenue Up 10% to $21.5M; Net Income $1.7M or $0.15 EPS</title>        <link>http://www.exac.com/news/exactech-q3-revenue-up-10-to-21.5m-net-income-1.7m</link>        <description>Gainesville, FL, October 26, 2005 -- Exactech, Inc. (Nasdaq: EXAC) announced today that revenue for the third quarter of 2005 increased 10% to $21.5 million from $19.5 million in the third quarter of 2004. Diluted earnings per share for the quarter were $0.15 on net income of $1.73 million compared to diluted earnings per share of $0.14 on net income of $1.68 million.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>gflowers</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2008-02-25T13:39:24Z</dc:date>        <dc:type>News Item</dc:type>    </item>
    <item rdf:about="http://www.exac.com/news/exactech-announces-fda-clearance-of-connexion-gxl">        <title>Exactech Announces FDA Clearance of Connexion GXL Enhanced Polyethylene Hip Acetabular Liner</title>        <link>http://www.exac.com/news/exactech-announces-fda-clearance-of-connexion-gxl</link>        <description>Gainesville, FL, October 11, 2005 -- Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products including orthopaedic implants and biologic materials, announced today that the company’s new Connexion™ GXL enhanced polyethylene acetabular liners for its AcuMatch® A-Series system has received 510(k) clearance from the U.S. Food and Drug Administration. The product launch is underway and will continue for the next several months.</description>        <dc:publisher>No publisher</dc:publisher>        <dc:creator>gflowers</dc:creator>        <dc:rights></dc:rights>                    <dc:subject>Press Releases</dc:subject>                <dc:date>2008-02-25T13:39:55Z</dc:date>        <dc:type>News Item</dc:type>    </item>




</rdf:RDF>
